Picture of Shenzhen Hepalink Pharmaceutical Co logo

9989 Shenzhen Hepalink Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Shenzhen Hepalink Pharmaceutical's 2022 Net Profit Down 202.0% Y/Y

March 29 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd  002399.SZ :
    * SAYS 2022 NET PROFIT DOWN 202.0% Y/Y AT 727.1 MILLION YUAN
($105.63 million)

    Source text
  
Further company coverage:  002399.SZ 

($1 = 6.8835 Chinese yuan renminbi)

 (Reporting by Hong Kong newsroom)
 ((twinnie.siu@tr.com; 852-3462 7715;))

Recent news on Shenzhen Hepalink Pharmaceutical Co

See all news